Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road Database
News for Outlets

Chinese company Bloomage Biotech forges partnership with Japanese firms on regenerative medicine

June 24, 2022


Abstract : Bloomage Biotech (Hainan) Co., Ltd., a subsidiary of Bloomage Biotechnology Corporation Limited. (Bloomage Biotech, 688363.SH), has recently reached strategic cooperation agreement with Japanese firms ROHTO Pharmaceutical Co., Ltd. (ROHTO) and BioMimetics Sympathies (BMS).

A worker operates at the workshop of a pharmaceutical company in Shijiazhuang, north China's Hebei Province, Jan. 14, 2022. (Xinhua/Yang Shiyao)

BEIJING, June 24 (Xinhua) -- Bloomage Biotech (Hainan) Co., Ltd., a subsidiary of Bloomage Biotechnology Corporation Limited. (Bloomage Biotech, 688363.SH), has recently reached strategic cooperation with Japanese firms ROHTO Pharmaceutical Co., Ltd. (ROHTO) and BioMimetics Sympathies (BMS), reported China Securities Journal Wednesday.

Under the partnership, the three companies will establish a joint venture with relevant parties. The joint venture will be settled in the Haikou National High-tech Zone of south China's Hainan Province, and will focus on research in regenerative medicine and cell culture medium, as well as related commercial operation.

The layout in regenerative medicine and cell culture medium will help Bloomage Biotech further enrich its key core technology matrix, and meanwhile enhance China's core technical strength in the fields, contributing to the implementation of the country's scientific and technological powerhouse strategy in biotechnology.

ROHTO Pharmaceutical Co., Ltd. mainly engages in the production and sales of pharmaceutical products, cosmetics and functional foods, etc. BioMimetics Sympathies specializes in regenerative medicine research and development.

(Edited by Zhang Yao, Gu Shanshan with Xinhua Silk Road, gushanshan.1987@163.com)

Scan the QR code and push it to your mobile phone

Keyword: Chinese company regenerative medicine

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Identifying code Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial